Praxis Genomics
About Praxis Genomics
Praxis Genomics provides advanced clinical genetic testing by integrating Whole Genome Sequencing, Optical Genome Mapping, and Transcriptome Sequencing for comprehensive genomic analysis. This multi-omic approach achieves high diagnostic sensitivity for unsolved genetic disorders and detailed cancer profiling. The company supports clinical decisions through expert genetic consulting and offers these advanced platforms for basic science research applications.
```xml <problem> Current genetic testing methods often fail to provide a molecular diagnosis for patients with inherited disorders, and a significant percentage of cancer patients do not receive treatments based on the specific molecular alterations of their illness. Existing methods may lack the sensitivity to detect structural variations and other complex genomic aberrations. </problem> <solution> Praxis Genomics offers comprehensive genetic testing and consulting services, combining optical genome mapping with whole-genome and transcriptome sequencing to improve diagnostic accuracy. This approach investigates the genome at the sequence, structure, and function levels simultaneously, providing a more complete picture of a patient's genetic makeup. By integrating these advanced technologies, Praxis Genomics aims to provide molecular-level diagnoses for difficult-to-solve inherited disorders and drive personalized therapeutic approaches for individuals with malignancies. The company's unique combination of testing services enables a higher percentage of cases with successful molecular diagnoses compared to traditional methods. </solution> <features> - Combines Bionano optical genome mapping technology with whole-genome and transcriptome sequencing for comprehensive genetic analysis. - Offers clinical genetic consulting with board-certified geneticists and pathologists to select appropriate tests and explain findings. - Provides somatic diagnostic testing to identify targeted therapies for cancer patients based on molecular alterations. - Offers constitutional diagnostic testing for individuals and families with suspected genetic diseases. - Provides carrier testing for individuals and couples to assess the risk of passing on genetic diseases to their children. - Utilizes the Saphyr Whole Genome Optical Mapping Instrument for high-level assessment of DNA breaks, rearrangements, and repeat expansions. - Employs DNBSEQ-T7 to generate high-quality data for whole-genome, exome, epigenome, and transcriptome sequencing. - Uses Illumina DRAGEN Bio-IT Platform for high-sensitivity detection of mutations and instability in repetitive regions. </features> <target_audience> The primary audience includes individuals with suspected genetic disorders, cancer patients seeking personalized treatment options, and couples planning to start a family who want to assess their risk of passing on genetic conditions. </target_audience> ```
What does Praxis Genomics do?
Praxis Genomics provides advanced clinical genetic testing by integrating Whole Genome Sequencing, Optical Genome Mapping, and Transcriptome Sequencing for comprehensive genomic analysis. This multi-omic approach achieves high diagnostic sensitivity for unsolved genetic disorders and detailed cancer profiling. The company supports clinical decisions through expert genetic consulting and offers these advanced platforms for basic science research applications.
Where is Praxis Genomics located?
Praxis Genomics is based in Atlanta, United States.
When was Praxis Genomics founded?
Praxis Genomics was founded in 2020.
- Location
- Atlanta, United States
- Founded
- 2020
- Employees
- 4 employees